L&G Pharma Breakthrough UCITS ETF
IE00BF0H7608
EquitiesThe fund aims to replicate the performance of an index that invests in global companies involved in innovative and disruptive pharmaceutical technologies. It focuses on high-growth potential companies that are at the forefront of research and development of new treatments and medicines.
Instruments
Price History
Asset Data
Manager
Legal & General Investment Management (LGIM)
Benchmark Index
Solactive Breakthrough Pharma Index
TER
0.49 %
Capitalization
74M
Capitalization Type
Acumulación